News & Articles
Piedmont Angel Network Two Announces Investment in Arbovax, an Early-Stage Vaccine Technology Development Company
Greensboro, NC – The Piedmont Angel Network Two (PAN Two), a structured, committed capital angel fund located in Greensboro, North Carolina, is pleased to announce that it led, along with contributions from management and individual investors,..

Arbovax, Inc and Immunobiosciences announce research collaboration
Arbovax, Inc (Arbovax) and Immunobiosciences, Inc (IBI) today announced that they will initiate research collaboration on the development of safe and effective vaccines for dengue,..


 
Welcome to Arbovax

ARBOVAX, Inc. has a unique technology that modifies arthropod-borne viruses (arboviruses) preventing them from replicating in mammalian cells. Arbovax will leverage this technology to facilitate development of a portfolio of improved vaccines against the worldwide threat of arthropod-borne diseases. read more

 
Spotlight on Dengue Fever

History of Dengue

Dengue Fever Perspectives
Occurance of Dengue Fevers

Arbovax.com © 2008. All rights reserved | Web Site developed by eCaribbean Ltd